Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Infermedica
HQ Poland · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
No adverse media involving Infermedica found in HSH's search of the last 24 months.
Cyber & information governance
No data breaches or cyber incidents involving Infermedica found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Infermedica says its Clinical AI Triage is an EU MDR Class IIb medical device registered with the MHRA. No recalls, safety notices or regulatory actions involving Infermedica found in HSH's search of the last 24 months.
Contract performance
Sep 2026: Infermedica announced a partnership with GP Triage to supply its AI triage engine within GP Triage's online access platform for NHS general practices; no named NHS sites were given.
Competitors
No competitors linked yet.